Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Noelle, Callizot"'
Autor:
Giulia Lunghi, Erika Di Biase, Emma Veronica Carsana, Alexandre Henriques, Noelle Callizot, Laura Mauri, Maria Grazia Ciampa, Luigi Mari, Nicoletta Loberto, Massimo Aureli, Sandro Sonnino, Michael Spedding, Elena Chiricozzi, Maria Fazzari
Publikováno v:
FEBS Open Bio, Vol 13, Iss 12, Pp 2324-2341 (2023)
Alterations in glycosphingolipid metabolism have been linked to the pathophysiological mechanisms of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease affecting motor neurons. Accordingly, administration of GM1, a sialic acid‐contain
Externí odkaz:
https://doaj.org/article/bc90ee2630b94cd7baec16a20f019b9f
Para-Substituted α‑Phenyl‑N-tert-butyl Nitrones: Spin-Trapping, Redox and Neuroprotective Properties
Autor:
Anaïs Deletraz, Béatrice Tuccio, Julien Roussel, Maud Combes, Catherine Cohen-Solal, Paul-Louis Fabre, Patrick Trouillas, Michel Vignes, Noelle Callizot, Grégory Durand
Publikováno v:
ACS Omega, Vol 5, Iss 48, Pp 30989-30999 (2020)
Externí odkaz:
https://doaj.org/article/732001ef09494668b2aa6b50129e2152
Autor:
Noelle Callizot, Alexandre Henriques, Laura Rouviere, Elodie Giorla, Bilal El Waly, Philippe Poindron
Publikováno v:
Alzheimer's & Dementia. 18
Para-Substituted α-Phenyl-N-tert-butyl Nitrones: Spin-Trapping, Redox and Neuroprotective Properties
Autor:
Patrick Trouillas, Anaïs Deletraz, Michel Vignes, Julien Roussel, Noelle Callizot, Catherine Cohen-Solal, Maud Combes, Béatrice Tuccio, Paul-Louis Fabre, Grégory Durand
Publikováno v:
ACS Omega
ACS Omega, Vol 5, Iss 48, Pp 30989-30999 (2020)
ACS Omega, Vol 5, Iss 48, Pp 30989-30999 (2020)
In this work, a series of para-substituted α-phenyl-N-tert-butyl nitrones (PBN) were studied. Their radical-trapping properties were evaluated by electron paramagnetic resonance, with 4-CF3-PBN being the fastest derivative to trap the hydroxymethyl
Autor:
Julien Laffaire, Serguei Nabirotchkin, Noelle Callizot, Philippe Rinaudo, Peter Schmitt, Daniel Cohen, Lydie Boussicault, Rodolphe Hajj
Publikováno v:
Journal of Neuroscience Research
There is currently no therapy impacting the course of amyotrophic lateral sclerosis (ALS). The only approved treatments are riluzole and edaravone, but their efficacy is modest and short‐lasting, highlighting the need for innovative therapies. We p
Autor:
Mirjana Antonijevic, Despoina Charou, Isbaal Ramos, Maria Valcarcel, Achille Gravanis, Patricia Villace, Noelle Callizot, Marc Since, Patrick Dallemagne, Ioannis Charalampopoulos, Christophe Rochais
Publikováno v:
European Journal of Medicinal Chemistry. 248:115111
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e102936 (2014)
Pyridoxine is used as a supplement for treating conditions such as vitamin deficiency as well as neurological disorders such as depression, epilepsy and autism. A significant neurologic complication of pyridoxine therapy is peripheral neuropathy thou
Externí odkaz:
https://doaj.org/article/e251711e2780449cb86f64a274bfb576
Publikováno v:
Neurobiology of Disease, Vol 8, Iss 4, Pp 626-635 (2001)
Sensory neuropathies are frequently associated with diabetes or with antimitotic treatments in humans suffering from cancer, and are in this case the most important limitation to the use of antimitotic drugs. For this reason, there is a need to estab
Externí odkaz:
https://doaj.org/article/2e839d93a05a454881268208240c9bca
Publikováno v:
Neurobiology of Disease, Vol 8, Iss 3, Pp 447-458 (2001)
The frissonnant (fri) mutation is an autosomic recessive mutation which spontaneously appeared in the stock of C3H mice. fri mutant mice have locomotor instability and rapid tremor. Since tremor ceases when mutant mice have sleep or are anaesthetized
Externí odkaz:
https://doaj.org/article/fb8494878ed04c85a8646ae98fdd2124
Publikováno v:
Alzheimer's & Dementia. 16